Found: 22
Select item for more details and to access through your institution.
Dynamic biomarker and imaging changes from a phase II study of pre‐ and post‐surgical sunitinib.
- Published in:
- BJU International, 2022, v. 130, n. 2, p. 244, doi. 10.1111/bju.15600
- By:
- Publication type:
- Article
Cost effectiveness of increasing the dose intensity of chemotherapy with granulocyte colony-stimulating factor in small-cell lung cancer: based on data from the Medical Research Council LU19 trial.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Multiparametric MRI for assessment of early response to neoadjuvant sunitinib in renal cell carcinoma.
- Published in:
- PLoS ONE, 2021, v. 16, n. 10, p. 1, doi. 10.1371/journal.pone.0258988
- By:
- Publication type:
- Article
Local alkylating chemotherapy applied immediately after 5-ALA guided resection of glioblastoma does not provide additional benefit.
- Published in:
- Journal of Neuro-Oncology, 2018, v. 136, n. 2, p. 273, doi. 10.1007/s11060-017-2649-8
- By:
- Publication type:
- Article
Speeding up the Evaluation of New Agents in Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2008, v. 100, n. 17, p. 1204, doi. 10.1093/jnci/djn267
- By:
- Publication type:
- Article
International Collaborative Ovarian Neoplasm trial 1: a randomized trial of adjuvant chemotherapy in women with early-stage ovarian cancer.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Clinical and biological markers predictive of treatment response associated with metastatic pancreatic adenocarcinoma.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 9, p. 1672, doi. 10.1038/s41416-023-02170-9
- By:
- Publication type:
- Article
Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Mini- BEAM is effective as a bridge to transplantation in patients with refractory or relapsed Hodgkin lymphoma who have failed to respond to previous lines of salvage chemotherapy but not in patients with salvage-refractory DLBCL.
- Published in:
- British Journal of Haematology, 2012, v. 157, n. 5, p. 543, doi. 10.1111/j.1365-2141.2012.09096.x
- By:
- Publication type:
- Article
Re-infused lymphocyte dose does not influence disease control following upfront autologous stem cell transplantation for multiple myeloma.
- Published in:
- British Journal of Haematology, 2012, v. 157, n. 4, p. 494, doi. 10.1111/j.1365-2141.2011.09023.x
- By:
- Publication type:
- Article
Final analysis of the UKLG LY02 trial comparing 6–8 cycles of CHOP with 3 cycles of CHOP followed by a BEAM autograft in patients <65 years with poor prognosis histologically aggressive NHL.
- Published in:
- British Journal of Haematology, 2010, v. 149, n. 2, p. 237, doi. 10.1111/j.1365-2141.2010.08081.x
- By:
- Publication type:
- Article
Chlorambucil versus observation after anti- Helicobacter therapy in gastric MALT lymphomas: results of the international randomised LY03 trial.
- Published in:
- British Journal of Haematology, 2009, v. 144, n. 3, p. 367, doi. 10.1111/j.1365-2141.2008.07486.x
- By:
- Publication type:
- Article
Reduced-intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on long-term outcomes.
- Published in:
- British Journal of Haematology, 2007, v. 139, n. 1, p. 70, doi. 10.1111/j.1365-2141.2007.06759.x
- By:
- Publication type:
- Article
Conventional second-line salvage chemotherapy regimens are not warranted in patients with malignant lymphomas who have progressive disease after first-line salvage therapy regimens.
- Published in:
- British Journal of Haematology, 2005, v. 130, n. 3, p. 363, doi. 10.1111/j.1365-2141.2005.05603.x
- By:
- Publication type:
- Article
Trajectories of Haemoglobin and incident stroke risk: a longitudinal cohort study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
PROphylaxis for paTiEnts at risk of COVID-19 infecTion (PROTECT-V)
- Published in:
- Trials, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s13063-023-07128-z
- By:
- Publication type:
- Article
Quality of life with cediranib in relapsed ovarian cancer: The ICON6 phase 3 randomized clinical trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A randomised, two-arm (1:1 ratio), double blind, placebo controlled phase III trial to assess the efficacy, safety, cost and cost-effectiveness of Rituximab in treating de novo or relapsing NS in patients with MCD/FSGS (TURING).
- Published in:
- BMC Nephrology, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s12882-024-03576-0
- By:
- Publication type:
- Article
Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2010, v. 37, n. 10, p. 1824, doi. 10.1007/s00259-010-1490-5
- By:
- Publication type:
- Article
Refining the Intraoperative Identification of Suspected High-Grade Glioma Using a Surgical Fluorescence Biomarker: GALA BIDD Study Report.
- Published in:
- Journal of Personalized Medicine, 2023, v. 13, n. 3, p. 514, doi. 10.3390/jpm13030514
- By:
- Publication type:
- Article
Novel designs for multi-arm clinical trials with survival outcomes with an application in ovarian cancer.
- Published in:
- Statistics in Medicine, 2003, v. 22, n. 14, p. 2239, doi. 10.1002/sim.1430
- By:
- Publication type:
- Article
Advanced Hodgkin lymphoma in the East of England: a 10-year comparative analysis of outcomes for real-world patients treated with ABVD or escalated-BEACOPP, aged less than 60 years, compared with 5-year extended follow-up from the RATHL trial.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 4, p. 1049, doi. 10.1007/s00277-021-04460-9
- By:
- Publication type:
- Article